Rare lephants
Screener

Lexicon Pharmaceuticals, Inc.

LXRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
EFFECT Aug 14, 2026
S-3 Aug 6, 2026 S-3
S-8 Aug 6, 2026 S-8
10-Q Aug 6, 2026 10-Q
SCHEDULE 13G/A Aug 6, 2026
8-K Aug 6, 2026 8-K
4 Jun 4, 2026 PRIMARY DOCUMENT
4 Jun 4, 2026 PRIMARY DOCUMENT
4 Jun 4, 2026 PRIMARY DOCUMENT
4 Jun 4, 2026 PRIMARY DOCUMENT
4 Jun 4, 2026 PRIMARY DOCUMENT
4 Jun 4, 2026 PRIMARY DOCUMENT
4 Jun 4, 2026 PRIMARY DOCUMENT
4 May 8, 2026 4
SCHEDULE 13D/A May 8, 2026
10-Q May 7, 2026 10-Q
8-K May 7, 2026 8-K
8-K May 6, 2026 8-K
4 May 4, 2026 PRIMARY DOCUMENT
4 May 4, 2026 PRIMARY DOCUMENT
4 May 4, 2026 PRIMARY DOCUMENT
4 May 4, 2026 PRIMARY DOCUMENT
4 May 4, 2026 PRIMARY DOCUMENT
4 May 4, 2026 PRIMARY DOCUMENT
4 May 4, 2026 PRIMARY DOCUMENT
← Newer Page 1 of 56 · 1394 filings Older →